Medico Intercontinental Limited has notified BSE Limited of an upcoming Board of Directors meeting, scheduled to be held on Friday, May 22, 2026. The meeting will take place at the company's registered office located at 1-5th Floor, Aditraj Arcade, Nr Karma Shreshtha Tower, 100 Ft Rd, Satellite, Ahmedabad, Gujarat – 380015. The intimation was issued on May 14, 2026, in compliance with Regulations 29, 30, and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The primary purpose of the meeting is to consider, approve, and take on record the Audited Financial Results of the company for the quarter and financial year ended March 31, 2026. The results will cover both Standalone and Consolidated financials. Any other business items as per the agenda circulated may also be addressed during the meeting.

Key details of the scheduled board meeting are outlined below:

Trading Window Closure

In continuation of its earlier intimation dated March 30, 2026, Medico Intercontinental Limited has confirmed that the trading window for dealing in the securities of the company has been closed with effect from April 1, 2026. This closure applies to all designated persons, including insiders, in compliance with the provisions of the SEBI (Prohibition of Insider Trading) Regulations and the company's Code of Conduct for Prevention of Insider Trading.

The trading window will remain closed until the conclusion of 48 hours after the declaration of the financial results for the quarter and financial year ended March 31, 2026. The intimation was signed by Samir D Shah, Managing Director (DIN: 03350268), on behalf of Medico Intercontinental Limited.

Medico Intercontinental Limited has successfully submitted its Annual Secretarial Compliance Report for the financial year ended 31st March, 2026, demonstrating exemplary regulatory compliance across all examined parameters. The report was submitted to BSE Limited on April 16, 2026, in accordance with Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Clean Compliance Record Achieved

The secretarial compliance report, conducted by M/s. Agarwal & Mehta Company Secretaries LLP, revealed no deviations or violations during the period under review. The comprehensive examination covered multiple SEBI regulations and guidelines, with the company achieving full compliance across all applicable areas.

Regulatory Framework Examination

The compliance assessment examined adherence to key SEBI regulations including:

• Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
• Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
• Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015
• Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018

Several regulations were not subject to examination as no related activities were undertaken during the review period, including Issue of Capital, Buyback of Securities, Share Based Employee Benefits, and Issue and Listing of Non-Convertible Securities regulations.

Key Compliance Highlights

The report highlighted several areas of strong compliance performance:

Corporate Governance Excellence:

• All required policies adopted with board approval and timely updates
• Functional website maintained with proper document dissemination
• Performance evaluation conducted for Board, Independent Directors, and Committees

Regulatory Adherence:

• All related party transactions obtained prior audit committee approval
• Complete compliance with Regulation 30 disclosure requirements within prescribed timelines
• Proper insider trading regulation compliance maintained

Notable Regulatory Interaction

The report disclosed that the company received a compliance observation notice from BSE Limited regarding Regulation 46 of SEBI (LODR) 2015 related to website disclosures. The company promptly addressed all required updates, and no further action was initiated by BSE Limited, demonstrating responsive compliance management.

Professional Certification

The compliance report was certified by Yash Mehta, Partner at Agarwal & Mehta Company Secretaries LLP, with FCS No. 12143 and C.P. No. 16535. The certification was issued on April 16, 2026, from Ahmedabad, with UDIN: F012143H000114432 and Peer Review No. 6717/2025.

The clean compliance record reflects Medico Intercontinental Limited's commitment to maintaining high standards of corporate governance and regulatory adherence, providing confidence to stakeholders about the company's operational integrity and compliance culture.